Presolicitation
Trazodone
Dept of Defense · Defense Logistics Agency · Sol. SPE2D2-26-R-0003
No deadline
AI summary Beta
The Defense Logistics Agency plans a national requirements contract for Trazodone HCL tablets (50 mg and 100 mg, in bottles of 90, 100, 500 and 1,000). It will be an unrestricted, fully competitive buy for a base year plus four option years, supplying DoD, VA, Indian Health Service and Bureau of Prisons customers through prime vendor programs. The solicitation was projected for November 2025.
Watch out for
- Pharmaceutical manufacturing or supply. This is a drug product buy under prime vendor programs, so it favors manufacturers or established distributors with the right FDA and supply chain standing, which is hard for a new small business.
- National requirements contract. The winner becomes the national supply source for several federal customers, and the actual quantities are not guaranteed.
A contract resulting from this solicitation will establish a national supply source
Read from the notice text only.
Full brief
What they want
- Trazodone HCL 50 MG tablets in 90, 100, 500 and 1,000 count bottles
- Trazodone HCL 100 MG tablets in 90, 100, 500 and 1,000 count bottles
- Serve as a national supply source for DoD, VA, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs
- Contract type
- Firm-fixed-price requirements contract (FAR 52.216-21), commercial item under FAR Part 12
- Period of performance
- 1 base year + 4 one-year options
- How to submit
- The solicitation will be posted on DIBBS (dibbs.bsm.dla.mil) and SAM.gov; send questions to Nancy Fernandez at nancy.fernandez@dla.mil
What to include when you submit
- Projected solicitation date was November 2025; DLA may issue it earlier or later
- Annual usage estimates will be in the Schedule of Supplies section of the solicitation
- Set up automated notifications for solicitation changes
You must have
- Open to all sources; no set-aside
This will be an unrestricted and fully competitive acquisition.
Not in the notice text
- Annual usage estimates (to come in the solicitation)
- Evaluation method and factors
- Required licenses, FDA or other compliance (not stated)
- Whether the solicitation has been issued yet, since the notice is from October 2025
Is this a fit for your business?
Create a free accountFedReady checks notices like this against your business profile, tracks deadlines, and alerts you to new matches. Creating an account is free.
Key facts
- Posted
- Oct 20, 2025
- Notice type
- Presolicitation
- Solicitation
- SPE2D2-26-R-0003
- Agency
- Dept of Defense · Defense Logistics Agency
- Office
- DLA Troop Support
- NAICS
- 325412
- Product/service code
- 6505
- Business type
- Medical & healthcare
- Contracting contact
- Nancy Fernandeznancy.fernandez@dla.mil445-737-0713
Full notice text from SAM.gov
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Trazodone HCL Tablets. Procurement details follow. Trazodone HCL 50 MG Tablets in 90, 100, 500, and 1,000 count bottles and Trazodone HCL 100 MG Tablets in 90, 100, 500, and 1,000 count bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency. A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/. Interested parties should contact Nancy Fernandez (445-737-0713) (nancy.fernandez@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is November of 2025. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Similar open opportunities
- Latanoprost Ophthalmic Solution (VA-27-00006027)The VA Enterprise Procurement Office plans an unrestricted RFP for Latanoprost eye drops for the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health Care Center.
- Imatinib TabletsThe VA Enterprise Procurement Office plans an unrestricted RFP for Imatinib Mesylate tablets to supply the VA, DoD, Bureau of Prisons, Indian Health Service and Federal Health…
- Methylphenidate ERThe Defense Logistics Agency (DLA Troop Support) plans a national requirements contract for Methylphenidate ER tablets (18, 27, 36 and 54 mg, 100-count bottles).
- Epinephrine InjectorThe Defense Logistics Agency (DLA Troop Support) is soliciting a national requirements contract for epinephrine 0.3 mg auto-injectors, to supply Department of Defense, VA, Indian…
- Prednisolone 1% Ophthalmic Solution